metabolomics

Researchers with the International Agency for Research on Cancer have published a prospective study analysing pre-diagnostic plasma metabolomics and the risk of triple-negative breast cancer within the European Prospective Investigation into Cancer and Nutrition (EPIC). The work examines whether metabolic signatures measured in blood before diagnosis are associated with later development of this aggressive breast cancer subtype. Details on the strength of the findings were not provided.